Internet-administrated Treatment of Anxiety Symptoms for Young Adults

Depression Clinical Trial

— NOVA-IV  

Official title:

Tailored Internet-administrated Treatment of Anxiety Symptoms for Young Adults

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01402258
• Other study ID #: GA-FORSS-2011-150291
• Status: Completed
• Phase: N/A
• Start date: April 2011
• Est. completion date: June 2015

Study information

• Verified date: December 2023
• Source: Linkoeping University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine whether tailored internet-administrated CBT is a feasible approach in the treatment of anxiety symptoms and comorbid anxiety and depressive symptoms in a clinical setting.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 15
• Est. completion date: June 2015
• Est. primary completion date: December 2014
• Accepts healthy volunteers: No
• Gender: All
• Age group: 16 Years to 25 Years

Eligibility

Inclusion Criteria:

• Be between the ages of 16-25 years old

• Have anxiety symptoms and/or anxiety syndrome

Exclusion Criteria:

• Suicide prone

• Alcohol addiction

• Ongoing psychological treatment

Related Conditions & MeSH terms

• Anxiety Disorders
• Depression

Intervention

Behavioral:
• Tailored Internet-administrated CBT-Treatment
This intervention contains 6-8 text-based self-help modules in which 4 modules are fixed (the first three and the last) and the rest are prescribed following the diagnostic telephone interview. These modules contain material on panic disorder, social phobia, stress management, assertiveness training, concentration, relaxation among other things.

Locations

Country	Name	City	State
Sweden	Department of Behavioral Sciences and Learning, Linköping University	Linköping	Östergötland

Sponsors (1)

Lead Sponsor	Collaborator
Linkoeping University

Country where clinical trial is conducted

Sweden, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Beck Anxiety Inventory (BAI)- Change from baseline	Change from baseline in anxiety symptoms two weeks post treatment, at six months and at 12 months post treatment.	Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatment
Secondary	Quality of Life Inventory (QOLI)- Change from baseline	Change from baseline in quality of life statements two weeks post treatment, at six months and at 12 months post treatment.	Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatment
Secondary	Montgomery Åsberg Depression Rating Scale-Self Rated (MADRS-S)- Change from baseline	Change from baseline in depressive symptoms two weeks post treatment, at six months and at 12 months post treatment.	Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatment
Secondary	Clinical Outcome in Routine Evaluation - Outcome Measure (CORE-OM)- Change from baseline	Change from baseline in anxiety and depressive symptoms two weeks post treatment, at six months and at 12 months post treatment.	Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatment